BMC Medical Genomics

official impact factor 3.77

Section Editors

  • Debashis Ghosh, Pennsylvania State University
  • Struan Grant, Children's Hospital of Philadelphia
  • Patrice Morin, National Institute on Aging, NIH
  • Patrick Tan, Graduate Medical School Singapore

Executive Editor

  • Tim Sands , BioMed Central

Articles

There has been an error retrieving the data. Please try again.
  • Image attributed to: Credit: Messer Woland, CC-BY-SA-2.5

    Predicting chemotherapy response

    Two new gene expression signatures can predict how breast cancer tumors will respond to two of the common kinds of chemotherapy, highlighting the potential of target-based gene expression indices to predict patient response to drug therapy.

    BMC Medical Genomics 2012, 5:16
  • Image attributed to: Credit: Drpoulette on Flickr, Creative Commons 2

    Identification of birth weight-related genes

    Profiling of inter-individual DNA methylation differences in neonates has identified 23 genes that account for 70-87% of variance in birth weight, whilst traditional gene expression profiling identified a far smaller proportion.

    BMC Medical Genomics 2012, 5:10
  • Image attributed to: Credit: User Nepron on Wikipedia, Creative Commons 3

    BPL method detects ovarian cancer biomarkers

    Aberrant patterns of methylation are found in samples from patients with ovarian cancer using the new bisulphate PCR-Luminex (BPL) method, highlighting H19 and PEG1 as potential biomarkers for the disease.

    BMC Medical Genomics 2012, 5:8
  • Image attributed to: Credit: iStockphoto

    Predicting early atherosclerosis

    An new set of 56 gene expression biomarkers could be used to predict early atherosclerosis from leukocytes before the symptoms of heart disease have developed, and this test can be further refined to identify very high risk patients.

    BMC Medical Genomics 2012, 5:2
  • View more articles  

RSS

Comments

View more comments

Scope

BMC Medical Genomics is an open access, peer-reviewed journal that considers articles on all aspects of functional genomics, genome structure, genome-scale population genetics, epigenomics, proteomics, systems analysis, and pharmacogenomics in relation to human health and disease.

It is journal policy to publish work deemed by peer reviewers to be a coherent and sound addition to scientific knowledge and to put less emphasis on interest levels, provided that the research constitutes a useful contribution to the field.

Quote

Sally Blower

"I strongly believe in the internet and open-access publishing in order to achieve scientific outreach both within academia and outside academia. Open-access allows anyone in the world with access to a computer to access scientific research. These innovative journals are becoming extremely successful and will change the nature of scientific publishing and increase the accessibility of science."

Professor Sally Blower
Semel Institute for Neuroscience & Human Behavior,
UCLA David Geffen School of Medicine, USA

Email updates

Receive periodic news and updates relating to BioMed Central.

Indexed by

  • BIOSIS
  • CAS
  • Embase
  • Index Copernicus
  • MEDLINE
  • PubMed
  • Science Citation Index Expanded
  • Scopus

View all

ISSN: 1755-8794